Clinical Trial Update: LPD+α-ketoacids on Autophagy and Improving Muscle Wasting in CKD [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating LPD+α-ketoacids for muscular atrophy in chronic kidney disease; current study status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Muscular Atrophy

Drugs mentioned

• LPD+α-ketoacids

Snippet

Sponsor: YUAN Wei-jie | Conditions: Muscular Atrophy | Phase 4 | Status: UNKNOWN